Pfizer Agrees To Buy Wyeth For $68 Billion

By: Associated Press Email
By: Associated Press Email

Stay up-to-date with KAKE News:

Monday, January 26, 2009

Pharmaceutical giant Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion cash-and-stock deal that could reshape the drug development industry.

Pfizer also says its net income for the fourth quarter dropped 90% from a year ago, hurt by a charge to resolve investigations into off-label promotional practices. It also plans to cut its work force by about 10 percent, and reduce the number of manufacturing sites.

New York-based Pfizer says it will pay $50.19 per share under the deal with Wyeth, valuing Madison, N.J.-based Wyeth at a 14.7% premium to the company's closing price of $43.74 Friday. Both companies' boards of directors approved the deal.

Pfizer says the deal is expected to add to the company's fourth-quarter adjusted profit. It expects to close the deal during the third or fourth quarter.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KAKE TV 1500 N. West Street Wichita, KS 67203-1323 (316) 943-4221
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 38322964 - kake.com/a?a=38322964